Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept + Ozurdex vs Ozurdex in DME (COLLIDE)
NCT03629210Phase 2Withdrawn
- Start
- Sep 2019
- Primary completion
- Feb 2021
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of dexamethasone in diabetic macular edema (DME). Planned start Sep 2019; status: withdrawn.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03629210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03629210.